Bronchoscopic injection of absolute ethanol in patients with persistent air leak from chest tube drainage
분야
의약학 > 내과학
저자
( Ah Leum Lim ) , ( Cheol Hong Kim ) , ( In Gyu Hyun )
발행기관
대한내과학회
간행물정보
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 194(총1쪽)
파일형식
42846539.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: Chest tube drainage (CTD) has indicated for the treatment of pneumothorax, hemothroax and after thoracic surgery. But, in the case of incomplete lung expansion and/or persistent air leak from CTD, medical or surgical thoracoscopy or, if that is unavailable, limited thoracotomy should be considered. We evaluate the efficacy of bronchoscopic injection of absolute ethanolamine to control persistent air leak in patients with CTD. Methods: Patients who had persistent or prolonged air leak from CTD were included consecutively. We directly injected 1.0 ml aliquots of ethanolamine into a subsegmental or its distal bronchus where is probably air leakage site, 1 to 20 times using injection needle through a fiberoptic bronchoscope. Results: 15 patients (all men) were enrolled. There were 14 spontaneous pneumothorax (5 idiopathic, 6 chronic obstructive pulmonary disease (COPD) and 3 post-tuberculosis) and 1 empyema associated with broncho-pleural fistula in the study. Of 14 patients with ethanolamine injection therapies, five had previous surgical therapy, wedge resection for bullae, but the others didn`t have. Twelve were successfully treated by an ethanolamine injection therapy alone. But three (idiopathic, COPD and post-tuberculosis) were failed and followed by a surgery (2 cases) or pleurodesis (1 case). Minor complications such as fever, chest pain and transient pneumonic infiltrations occurred after the therapy. With successful, the time to discharge was about 3 days (median). Conclusions: Bronchoscopic ethanolamine injection therapy may be partially useful in controlling air leakage and reducing the hospital stay in patients with CTD.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.